Vacuna virus papiloma huma

HPV vaccination, key to cervical cancer prevention

Solidarity in Business Programme April 2023

The healthy advice of the month:

VACCINATION AGAINST PPHV, KEY TO CERVICAL CANCER PREVENTION

Your health, first. April 2023

Almost one in five cases of cancer worldwide is caused by bacteria, viruses and other infectious agents, although they are not normally associated with cancer. One of the most important infections related to cancer cases is that caused by the human papillomavirus (HPV). This virus is responsible for more than 100,000 cases of cancer in Europe. The frequency of HPV infection in women in Spain is 14.3%, but increases to 29% in young women aged between 18 and 25. Furthermore, it is estimated that up to 50% of people carry the virus at some point in their lives.

Vaccination is the most effective way to prevent the health effects of this virus. In 2007 it was recommended for adolescent women and later, in 2018, it was approved for the population of both sexes at risk.

From 2022 onwards, the Ministry of Health also recommends vaccination against HPV for men aged between 12 and 18, which will be included in the childhood vaccination strategy of all communities by the end of 2024.

If you want more information about what the human papillomavirus is and how it is transmitted, we invite you to visit the blog of the Association Against Cancer.

For more information: Vaccination against HPV, key in the prevention of cervical cancer | Association against cancer in Spain.

Lymphography published by the AECC against the human papilloma virus